Skip to main content

Table 1 Patient characteristics and degree of anemia at enrollment

From: Antiretroviral treatment reverses HIV-associated anemia in rural Tanzania

Variables Normal
n (%)
Mild anemiaa
n (%)
Moderate anemiab
n (%)
Severe anemiac
n (%)
P
All (n = 838) 189 (22.6) 269 (32.1) 238 (28.4) 142 (16.9)  
Gender      0.046
   Female 115 (21.1) 165 (30.3) 171 (31.4) 94 (17.2)  
   Male 74 (25.2) 104 (35.5) 67 (22.9) 48 (16.4)  
Age (years)      0.726
   <30 40 (20.1) 61 (30.7) 61 (30.7) 37 (18.6)  
   30-39 75 (22.1) 106 (31.3) 98 (28.9) 60 (17.7)  
   ≥40 74 (24.7) 102 (34.0) 79 (26.3) 45 (15.0)  
AIDSd      <0.001
   Yes 48 (12.0) 109 (27.3) 146 (36.6) 96 (24.1)  
   No 141 (32.1) 160 (36.4) 92 (21.0) 46 (10.5)  
Tuberculosise      0.001
   Yes 9 (9.2) 34 (34.7) 28 (28.6) 27 (27.5)  
   No 180 (24.3) 235 (31.8) 210 (28.4) 115 (15.5)  
BMI (kg/m2)f      <0.001
   <16 17 (8.8) 49 (25.4) 67 (34.7) 60 (31.1)  
   16-18.4 46 (19.7) 74 (31.8) 76 (32.6) 37 (15.9)  
   ≥18.5 118 (33.5) 134 (38.1) 76 (21.6) 24 (6.8)  
MCV (fL)      <0.001
   <80 36 (11.7) 90 (29.2) 116 (37.7) 66 (21.4)  
   ≥80 153 (28.9) 179 (33.8) 122 (23.0) 76 (14.3)  
MCH (pg)      <0.001
   <26 35 (10.3) 95 (27.9) 130 (38.1) 81 (23.7)  
   ≥26 154 (31.0) 174 (35.0) 108 (21.7) 61 (12.3)  
  1. aHemoglobin 10-12 g/dL (10-13 g/dL for men). bHemoglobin 8-10 g/dL. cHemoglobin <8 g/dL. dWorld Health Organization clinical stage 4. eOn tuberculosis treatment at enrollment. f60 values missing (n = 778).
  2. BMI, body mass index; MCV, mean cell volume; MCH, mean corpuscular hemoglobin.